Loading…
Based on limited metadata, this FDA Warning Letter issued to Vapestar on May 31, 2018, concerns an "Other" product category, though the specific nature of violations is not available from the subject line provided. The letter indicates regulatory concerns from the FDA, likely related to product manufacturing, marketing, or compliance practices, but without access to the full warning letter text, the precise violations and regulatory scope cannot be detailed. The issuing office information is also unavailable, which would typically clarify whether concerns involve product quality, labeling, pre-market authorization, or other regulatory requirements.